Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.42 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | P4HB | P07237 | 1/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30951710 | 1.00 | LPL (0.42) | LPLLIPGPRMT5WDR77EGFR | |
| SCHEMBL20222384 | 0.99 | LPL (0.41) | LPLLIPGPRMT5WDR77EGFR | |
| SCHEMBL29808659 | 0.95 | LPL (0.42) | LPLLIPGPRMT5WDR77EGFR | |
| SCHEMBL19298341 | 0.95 | LPL (0.42) | LPLLIPGPRMT5WDR77EGFR | |
| SCHEMBL19298375 | 0.92 | LPL (0.42) | LPLLIPGPRMT5WDR77EGFR | |
| SCHEMBL15713955 | 0.92 | LPL (0.42) | LPLLIPGPRMT5WDR77EGFR | |
| SCHEMBL29602735 | 0.92 | LPL (0.42) | LPLLIPGPRMT5WDR77EGFR | |
| SCHEMBL29808477 | 0.92 | LPL (0.42) | LPLLIPGPRMT5WDR77EGFR | |
| SCHEMBL12181998 | 0.92 | LPL (0.49) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL17780741 | 0.92 | LPL (0.49) | LPLLIPGPRMT5WDR77P4HB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542258-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-01-03 | — | — | US | disclosed |
| CN-108290854-B | Heterocyclic compound and organic light-emitting device comprising same | 株式会社LG化学 | 2022-08-23 | — | — | CN | disclosed |
| WO-2022131743-A1 | ORGANIC LUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 솔루스첨단소재 주식회사 | 2022-06-23 | — | — | WO | disclosed |
| WO-2021080254-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2021-04-29 | — | — | WO | disclosed |
| WO-2021045444-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2021-03-11 | — | — | WO | disclosed |
| US-20200262825-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200262825-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CYP1A1, CYP1B1 | LPL 3909/4885LIPG 4100/4885PRMT5 2967/4885 |
| US-11542258-B2 | Heterocyclic compound and organic light emitting device comprising the same | CYP1A1, CRY1, CYP1B1 | LPL 3827/4885LIPG 4073/4885PRMT5 3301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.